Clearly it is a positive. It should set the stage for the deal to be closed in September. |
I'm not saying Abbott is going to buy them tomorrow, but I think it's the first friendly overture that could lead to a long relationship. |
I've been a little perplexed. I've always felt that Boston Scientific offers have been superior. I've not understood the loyalty of Guidant's board to J&J. |
Six months ago, people believed there was good chance he (Tobin) would leave. |
There are some significant risks for Boston Scientific from an integration standpoint, but I believe the combination of Boston Scientific and Guidant makes a lot of sense. |
They have really alleviated the issues about an antitrust review. |
They missed the (forecast) by $1 million, and it's a very choppy tape for small medical device companies. |
Underneath the covers I believe that Abbott wants to be a device player and for the first time they are making a real legitimate stand to become one. If Boston doesn't get Guidant, at this valuation, I think Abbott ultimately buys Boston. |
We were extremely impressed by the solid results posted in the first quarter and would be buyers of the stock at current levels. |
We're supporting it because it's a huge opportunity. |